Royce & Associates LP boosted its stake in shares of Enovix Co. (NASDAQ:ENVX - Get Rating) by 20.0% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 96,000 shares of the company's stock after purchasing an additional 16,000 shares during the period. Royce & Associates LP owned about 0.06% of Enovix worth $1,760,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in ENVX. Quantbot Technologies LP purchased a new position in shares of Enovix during the 2nd quarter valued at $26,000. Emerald Advisers LLC acquired a new position in Enovix in the 3rd quarter worth about $62,000. Ensign Peak Advisors Inc acquired a new position in Enovix in the 1st quarter worth about $67,000. Sierra Capital LLC purchased a new stake in shares of Enovix during the 2nd quarter worth about $47,000. Finally, Allspring Global Investments Holdings LLC acquired a new stake in shares of Enovix during the 3rd quarter valued at about $113,000. Institutional investors and hedge funds own 55.62% of the company's stock.
In related news, insider Gardner Cameron Dales sold 30,000 shares of the firm's stock in a transaction on Tuesday, November 1st. The stock was sold at an average price of $18.55, for a total value of $556,500.00. Following the completion of the transaction, the insider now directly owns 899,565 shares of the company's stock, valued at $16,686,930.75. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, insider Gardner Cameron Dales sold 30,000 shares of the stock in a transaction dated Tuesday, November 1st. The shares were sold at an average price of $18.55, for a total value of $556,500.00. Following the completion of the transaction, the insider now owns 899,565 shares of the company's stock, valued at $16,686,930.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Harrold J. Rust sold 2,000 shares of the firm's stock in a transaction dated Tuesday, November 1st. The stock was sold at an average price of $18.77, for a total transaction of $37,540.00. Following the transaction, the chief executive officer now owns 1,365,531 shares of the company's stock, valued at approximately $25,631,016.87. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 41,000 shares of company stock worth $740,870. Company insiders own 20.60% of the company's stock.
NASDAQ:ENVX opened at $7.99 on Wednesday. Enovix Co. has a one year low of $6.50 and a one year high of $26.30. The company has a fifty day moving average price of $10.77 and a 200 day moving average price of $14.86.
Enovix (NASDAQ:ENVX - Get Rating) last released its earnings results on Tuesday, November 1st. The company reported ($0.20) earnings per share for the quarter, topping analysts' consensus estimates of ($0.21) by $0.01. The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.55 million. On average, equities analysts expect that Enovix Co. will post -0.77 EPS for the current fiscal year.
Several brokerages recently weighed in on ENVX. Cowen cut their price objective on shares of Enovix from $36.00 to $25.00 in a research report on Wednesday, November 2nd. B. Riley cut their price target on shares of Enovix from $19.00 to $18.00 in a report on Wednesday, January 4th. Canaccord Genuity Group began coverage on shares of Enovix in a report on Wednesday, January 11th. They issued a "buy" rating and a $20.00 price objective for the company. EF Hutton Acquisition Co. I began coverage on Enovix in a report on Friday, October 28th. They set a "buy" rating and a $25.00 target price on the stock. Finally, Cowen lowered their price objective on Enovix from $36.00 to $25.00 in a report on Wednesday, November 2nd. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $29.46.
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. The company was founded in 2007 and is headquartered in Fremont, California.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
